Seborrhea Therapeutic Pipeline Review H2 2014 Report at ReportsnReports.com
Dallas, TX (PRWEB) January 03, 2015 -- The report "Seborrhea Pipeline Review, H2 2014" provides comprehensive information on the therapeutic development for Seborrhea. Seborrhea is a common skin problem. It causes a red, itchy rash and white scales. It particularly affects the sebaceous-gland-rich areas of skin such as scalp, face and torso. Seborrhoeic dermatitis symptoms appear gradually and usually the first signs are flaky skin and scalp. Adults of all ages may develop seborrhea, too, especially on the scalp and face. Complete Report is Available @ http://www.reportsnreports.com/reports/321896-seborrhea-pipeline-review-h2-2014.html .
It also reviews key players involved in the therapeutic development for Seborrhea and special features on late-stage and discontinued projects. Companies discussed in this Seborrhea Pipeline Review H2 2014 report include Biomar Microbial Technologies, EpiPharm AG, Maruho Co., Ltd., NicOx S.A., Phosphagenics Limited, Valeant Pharmaceuticals International, Inc.
Drugs profile discussed in this Seborrhea Pipeline Review H2 2014 report include A-101, EPI-SK14, IB-07A081, IB-07A085, ketoconazole, lanoconazole, NCX-1047, Product-10156, Product-49778. Order a Purchase copy of this report @ http://www.reportsnreports.com/Purchase.aspx?name=321896 .
Table of Contents
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Seborrhea Overview 6
Therapeutics Development 7
Pipeline Products for Seborrhea - Overview 7
Pipeline Products for Seborrhea - Comparative Analysis 8
Seborrhea - Therapeutics under Development by Companies 9
Seborrhea - Pipeline Products Glance 10
Clinical Stage Products 10
Early Stage Products 11
Seborrhea - Products under Development by Companies 12
Seborrhea - Companies Involved in Therapeutics Development 13
Biomar Microbial Technologies 13
EpiPharm AG 14
Maruho Co., Ltd. 15
NicOx S.A. 16
Phosphagenics Limited 17
Valeant Pharmaceuticals International, Inc. 18
Seborrhea - Therapeutics Assessment 19
Drug Profiles 26
A-101 - Drug Profile 26
EPI-SK14 - Drug Profile 27
IB-07A081 - Drug Profile 28
IB-07A085 - Drug Profile 29
ketoconazole - Drug Profile 30
lanoconazole - Drug Profile 31
NCX-1047 - Drug Profile 32
Product-49778 - Drug Profile 34
Seborrhea - Recent Pipeline Updates 35
Seborrhea - Dormant Projects 36
Seborrhea - Discontinued Products 37
Seborrhea - Product Development Milestones 38
Featured News & Press Releases 38
Jun 30, 2014: Aclaris Therapeutics Announces Positive Results from Phase 2 Clinical Trial of A-101 for the Removal of Seborrheic Keratosis, a Common Type of Skin Tumor 38
List of Tables
Number of Products under Development for Seborrhea, H2 2014 7
Number of Products under Development for Seborrhea - Comparative Analysis, H2 2014 8
Number of Products under Development by Companies, H2 2014 9
Comparative Analysis by Clinical Stage Development, H2 2014 10
Comparative Analysis by Early Stage Development, H2 2014 11
Products under Development by Companies, H2 2014 12
Seborrhea - Pipeline by Biomar Microbial Technologies, H2 2014 13
Seborrhea - Pipeline by EpiPharm AG, H2 2014 14
Seborrhea - Pipeline by Maruho Co., Ltd., H2 2014 15
Seborrhea - Pipeline by NicOx S.A., H2 2014 16
Seborrhea - Pipeline by Phosphagenics Limited, H2 2014 17
Seborrhea - Pipeline by Valeant Pharmaceuticals International, Inc., H2 2014 18
Assessment by Monotherapy Products, H2 2014 19
Number of Products by Stage and Target, H2 2014 21
Number of Products by Stage and Mechanism of Action, H2 2014 23
Number of Products by Stage and Route of Administration, H2 2014 24
Number of Products by Stage and Molecule Type, H2 2014 25
Seborrhea Therapeutics - Recent Pipeline Updates, H2 2014 35
Seborrhea - Dormant Projects, H2 2014 36
Seborrhea - Discontinued Products, H2 2014 37
List of Figures
Number of Products under Development for Seborrhea, H2 2014 7
Number of Products under Development for Seborrhea - Comparative Analysis, H2 2014 8
Number of Products under Development by Companies, H2 2014 9
Comparative Analysis by Clinical Stage Development, H2 2014 10
Comparative Analysis by Early Stage Products, H2 2014 11
Assessment by Monotherapy Products, H2 2014 19
Number of Products by Top 10 Targets, H2 2014 20
Number of Products by Stage and Top 10 Targets, H2 2014 21
Number of Products by Top 10 Mechanism of Actions, H2 2014 22
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2014 23
Number of Products by Stage and Top 10 Routes of Administration, H2 2014 24
Number of Products by Stage and Top 10 Molecule Types, H2 2014 25
Explore more reports on Pharmaceuticals industry at http://www.reportsnreports.com/market-research/pharmaceuticals/ .
About Us:
ReportsnReports.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.
Ritesh Tiwari, ReportsnReports, http://www.reportsnreports.com, +1 (888) 391-5441, [email protected]
Share this article